World’s first vaccine for winter vomiting bug norovirus to be trialled in UK - Final phase of vaccine trial to start soon ...

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

As a long-term holding, Pfizer should benefit from demographic trends driving increased healthcare spending globally. The ...

The WHO said Friday it had for the first time prequalified a mpox vaccine -- a move expected to speed up access to the jabs ...

Building local capacity to manufacture drugs, vaccines, and health products is not enough. Officials must work to ensure ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Researchers at the University of Sheffield have been awarded funding for their infectious disease technology that could make ...

Dr. Franz-Werner Haas, Chief Executive Officer of LimmaTech, stated, “We are highly encouraged by the FDA’s Fast Track designation, which reinforces our efforts and underscores the significant ...

Mr Lowe said he would like the stigma taken out of Covid vaccine injuries. He said many people do not take them seriously. Mr ...